SCHEMBL6568616

SCHEMBL6568616

Cc1ccc(NC(=O)NCc2ccccc2)c(O)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 1/20 0.65
SMN1; SMN2 Q16637 3/20 0.60
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
NPC1 O15118 2/20 0.58
RAB9A P51151 2/20 0.58
HPGD P15428 2/20 0.58
TP53 P04637 1/20 0.58
GAA P10253 2/20 0.57
CA12 O43570 2/20 0.55
CA1 P00915 2/20 0.55
CA2 P00918 2/20 0.55
CA9 Q16790 2/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
CFD P00746 1/20 0.55
CYP2C19 P33261 2/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
KDM4E B2RXH2 3/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27942152 0.87 L3MBTL1 (0.71) SMN1; SMN2MEN1KMT2ANPC1RAB9A
SCHEMBL6565629 0.86 CXCR2 (0.62) CXCR2MEN1KMT2ANPC1RAB9A
SCHEMBL4347125 0.85 TRPV1 (0.65) GAACA12CA1CA2CA9
SCHEMBL4782120 0.83 CA2 (0.59) SMN1; SMN2GAACA12CA1CA2
SCHEMBL22588921 0.82 CFD (0.69) SMN1; SMN2MEN1KMT2ANPC1RAB9A
SCHEMBL10363016 0.81 KDM4E (0.74) SMN1; SMN2MEN1KMT2ANPC1RAB9A
SCHEMBL14224546 0.80 CXCR2 (0.60) CXCR2SMN1; SMN2MEN1KMT2ANPC1
SCHEMBL12846675 0.80 TRPV1 (0.62) SMN1; SMN2MEN1KMT2ANPC1RAB9A
SCHEMBL5595023 0.79 KDM4E (0.64) MEN1KMT2AGAACA12CA1
SCHEMBL5605320 0.79 CXCR2 (1.00) CXCR2SMN1; SMN2MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed